cancer diagnostic

Clearbridge Health rides on China's biotech boom for cancer diagnostic spinoff

SINGAPORE (Aug 31): Investors and foreign biotech veterans are making their way to China as the government aims to build a healthcare empire.

Jeremy Yee, former CEO of Cordlife Group and now running his second healthcare company Clearbridge Health, hopes to tap into that optimism. He plans to spin off a cancer diagnostics associate company that is aiming to expand into China, and buy more testing laboratories in the region. Yee hopes these moves will help revive investor interest in Clearbridge.

Be informed of the stories that matter